Major Depressive Episode Clinical Trial
— DEPIMAGEOfficial title:
Study of Functional Networks in Resting fMRI as Biomarkers of Monopolar or Bipolar Depression
Verified date | October 2017 |
Source | Assistance Publique - Hôpitaux de Paris |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The primary purpose is to compare with resting fMRI the functional networks of rest (RTS) in
unipolar depression and in bipolar depression.
Hypothesis : the main objective of this work is to compare with the rest fMRI the Rest
Functional Networks (RFN) in the unipolar depression and in the bipolar depression in order
to identify specific biomarkers for each affection. The general hypothesis of this work is
that intra- and inter RFN connectivity is different between bipolar patients and unipolar
patients. Specifically the investigators assume that connectivity within the default mode
network (including ventral mediofrontal cortex, subgenual cingulate cortex, inferior parietal
cortex, posterior cingulate cortex) will be increased in unipolar patients compared to
bipolar patients.
Status | Terminated |
Enrollment | 37 |
Est. completion date | June 2017 |
Est. primary completion date | November 18, 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Unipolar and bipolar depressed patients including patients with type I and type II bipolar disorders. - Patients in an acute depressive state (according to DSM-IV criteria). - Men or Women with age between 18 to 65 years. - Patients with unipolar depression must fullfill Mitchel's criteria for unipolar depression. - MADRS score > 22 - YMRS score < 12 - Mean duration of depressive episode < 1 year - in-patient or out-patient Healthy volunteers matched for age and socio-educational level, without personal history of unipolar or bipolar depression and without psychiatric disorders Exclusion Criteria: Patients and controls: - Bipolar disorder with rapid cycling - Suicidal thoughts with score > 3 at the MADRS item 'suicide' - Depression with psychotic features - Psychiatric co-morbidity including other AXIS-1 disorders (OCD, schizophrenia, social phobia) and borderline personality disorder - Substance and alcohol abuse or dependance - Recent treatment with ECT (< 6 months) - Previous history of Brain Traumatic Injury; neurological disorders (multiple sclerosis, parkinson's disease, stroke) or disorders associated with abnormal MRI (lupus, Behcet's disease) - Contra-indication of MRI: pregnancy; tatoos; claustrophobia - Patient hospitalized under legal condition - Patient that requires an important sedation due to anxiety - Bipolar patients that requires at less 3 mood stabilizers - Patient receiving a new antidepressant since more than 10 days - Patients without social security insurance - Patients with legal protection |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris | FoundaMental Mental Health Foundation RTRS (France) |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Bold signal and connectivity coefficients within and between neural networks | Bold connectivity assessed with resting state fMRI within and between networks | one day (within 16 days after inclusion) | |
Secondary | Correlations between clinical scores (MADRS, YMRS, SCID) and neural network connectivity. | Relationship between clinical variables and scores of connectivity within and between networks in unipolar and bipolar depressed patients | one day (within 16 days after inclusion) | |
Secondary | Sensibility and specificity of fMRI to predict unipolar and bipolar depressive status | relationships between clinical variables and scores of connectivity within and between networks in unipolar and bipolar depressed patients | one day (within 16 days after inclusion) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03256162 -
Ketamine as an Adjunctive Therapy for Major Depression
|
Phase 1 | |
Completed |
NCT01944293 -
Ketamine for Suicidality in Bipolar Depression
|
Phase 1/Phase 2 | |
Recruiting |
NCT01441505 -
A Study of Ketamine as an Antidepressant
|
Phase 2 | |
Active, not recruiting |
NCT03487926 -
Microglial Activation in Inflammatory Bowel Disease
|
||
Recruiting |
NCT04939649 -
Ketamine as an Adjunctive Therapy for Major Depression (2)
|
Phase 3 | |
Recruiting |
NCT05028738 -
Patient-oriented Randomized Pragmatic Feasibility Trial With rTMS in Depression and Anxiety
|
N/A | |
Recruiting |
NCT03646058 -
Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode
|
Phase 3 | |
Not yet recruiting |
NCT06117397 -
A Text Messaging Intervention to Reduce Perinatal Depression Risk
|
N/A | |
Completed |
NCT03735576 -
Cognitive Behavioural Therapy for the Treatment of Late Life Depression
|
N/A | |
Recruiting |
NCT04999553 -
Left vs. Right Non-Inferiority Trial
|
N/A | |
Completed |
NCT03716869 -
Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder
|
N/A | |
Recruiting |
NCT02824081 -
Neuroinflammation, Serotonin, Impulsivity and Suicide
|
N/A | |
Terminated |
NCT01099592 -
Antidepressants to Promote Recovery of Cardiac Patients Suffering From Depression
|
Phase 4 | |
Completed |
NCT03752853 -
Stress Systems and Psychotherapy in Depression
|
N/A | |
Recruiting |
NCT04480918 -
University of Iowa Interventional Psychiatry Service Patient Registry
|
||
Recruiting |
NCT04130958 -
Circuit-Based Approach to Suicide: Biomarkers, Predictors, and Novel Therapeutics
|
N/A | |
Completed |
NCT03190772 -
The Role of Expectations in the Pharmacological Treatment of Depression - An Experimental Investigation
|
N/A | |
Recruiting |
NCT04832750 -
Depression-Reduction by Accelerated Personalized NeuroModulation and Its Effects on Sleep
|
||
Terminated |
NCT02839798 -
NeoSync TMS Treatment for Bipolar I Depression
|
Phase 2 | |
Completed |
NCT00852592 -
Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
|
Phase 3 |